期刊文献+

CD44V6和MMP-2在乳腺癌中的表达及临床意义 被引量:4

原文传递
导出
摘要 目的:探讨CD44V6和MMP-2基因蛋白在乳腺癌中的表达及作用。方法;在22例乳腺良性组织和58例乳腺癌中应用流式细胞术定量检测CD44V6和MMP-2的表达。结果:CD44V6和MMP-2在乳腺癌中的表达均明显高于乳腺良性组织(P<0.05),二者均与乳腺癌淋巴转移及临床分期密切相关(P<0.05),且在乳腺癌中CD44V6和MMP-2的表达呈正相关。结论:CD44V6和MMP-2的高表达促进了乳腺癌的侵袭和转移,提示CD44V6和MMP-2可作为乳腺癌诊断和预后判断的指标。
出处 《中国妇幼保健》 CAS 北大核心 2013年第23期3833-3834,共2页 Maternal and Child Health Care of China
基金 廊坊市2010年科学技术研究与发展指令性计划〔2010117101-5〕
  • 相关文献

参考文献7

二级参考文献24

  • 1Fukuse T, Hirata T, Naiki H et al. Expression of proliferating cell nuclear antigen and CD44 variant isoforms in the primary and metastatic sites of non - small cell lung carcinoma with intrapuhnonary metastase [J]. Cancer, 1999, 86 (7): 1174.
  • 2Heider KH, Kuthan H, Stehle G, et al. CD44v6 : a target for anti- body - based cancer therapy. [ J ] Cancer Iramunol Immunother, 2004,53(7) :567 -579.
  • 3Heider KH, Kut han H, Stehle G, et al. CD44v6 : a target for antibody - based cancer therapy [ J ]. Cancer Immunol Immunother, 2004,53(7) :567 -579.
  • 4Nakopoulou L, Tsirmpa I, Alexandrou P, et al. MMP - 2 protein in invasive breast cancer and the impact of MMP - 2/TIMP - 2 phenotype on overall survival [J]. Breast Cancer Res Treat,2003, 77(2) :145 - 155.
  • 5Jones JL, Glynn P, WAlker RA. Expression of MMP - 2 and MMP -9 their inhibitors, and the activator MTI - MMP in primary breast carcinomas [ J]. J Pathol, 1999,189 (2) : 161 - 168.
  • 6Mita A C,Mita M M,Nawrocki ST,et al.Survivin:key regulator of mitosis and apoptosis and novel target for cancer therapeutics[J].Clin Cancer Res,2008,14(16):5000-5005.
  • 7Minard M E,Ellis L M,Gallick G E.Tiam 1 regulates cell adhe-sion,migration and apoptosis in colon tumor cells[J].Clin Exp Metasta-sis,2006,23(5-6):301-313.
  • 8Melet A,Song K,Bucur O,et al.Apoptotic pathways in tumor pro-gressin and therapy[J].Adv Exp Med Biol,2008,615:47-79.
  • 9Hermann B,Susanne H,Andreas B.Immunohistochemical expres-sion of survivin and[gamma]-H2AX in vulvar intraepithelial neoplasiaand low-stage squamous cell carcinoma[J].International Journal of Gy-necological Pathology,2011,30(6):583-590.
  • 10Vader G,Medema R H,Lens S M,et al.The chromosomal passengercomplex:guiding Aurora-B through mitosis[J].J Cell Biol,2006,173(6):833-837.

共引文献30

同被引文献46

  • 1皋岚湘,丁华野.免疫组织化学在乳腺疾病鉴别诊断中的应用[J].诊断病理学杂志,2006,13(1):8-12. 被引量:11
  • 2张丽华,孙荣超,陈瑛.乳腺浸润性微乳头状癌临床病理观察[J].诊断病理学杂志,2006,13(2):99-101. 被引量:5
  • 3Dowsett M,Nielsen T O,A′Hern R,et al.Assessment of Ki67 in breast cancer:recommendations from the international Ki67 in breast cancer working group[J].J Natl Cancer Inst,2011,103(22):1656-64.
  • 4Tavassoli F A,Devilee P.World Health Orangnization classification of tumors.Pathology and female gentital organs[M].Lyon:IARC Press,2003:35-6.
  • 5LunaMoré S,de los Santos F,Bretón J J,Caadas M A.Estrogen and progesterone cerbB2,p53 and Bcl2 in thirtythree invasive micropapillary breast carcinoma[J].Pathol Res Pract,1996,192(1):27-32.
  • 6Bae Y K,Gong G,Kang J,et al.Hormone receptor expression in invasive breast cancer among Korean women and comparison of 3 antiestrogen receptor antibodies:a multiinstitutional retrospective study using tissue microarrays[J].Am J Surg Pathol,2012,36(12):1817-25.
  • 7Walsh M M,Bleiweiss I J.Invasive micropapillary carcinoma of the breast:eighty cases of an underrecognized entity[J].Hum Pathol,2001,32(6):583-9.
  • 8Vingiani A,Maisonneuve P,Dell'orto P,et al.The clinical relevance of micropapillary carcinoma of the breast:a casecontrol study[J].Histopathology,2013,63(2):217-24.
  • 9Yu J I,Choi D H,Park W,et al.Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast:matched casecontrol study[J].Breast,2010,19(3):231-7.
  • 10Dowsett M, Nielsen TO, A'hem R. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer Working Group [ J ]. J Natl Cancer lnst, 2011, 103 (22) :1656 - 1664.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部